Besides the main objectives, there are other objectives as follows:~To evaluate efficacy of ALS-L1023 for liver fibrosis and steatosis by noninvasive imaging biomarker MRI-PDFF and MRE~To determine optimized dose of ALS-L1023 in NASH disease
The main objective of this study is to evaluate safety and efficacy of ALS-L1023 in patients with Non-alcoholic steatohepatitis